Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 27866840 | HLA-DRB1 (HLA-DRB1) | thrombotic thrombocytopenic purpura | NA | NA | NA | unclassified | |
| the role of human leukocyte antigen drb1-dqb1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura. | |||||||
| 27866840 | HLA-DQB1 (HLA-DQB1) | thrombotic thrombocytopenic purpura | NA | NA | NA | unclassified | |
| the role of human leukocyte antigen drb1-dqb1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura. | |||||||
| 29567779 | HLA-DRB1*11 | thrombotic thrombocytopenic purpura | NA | NA | NA | only_studied | |
| several studies have identified the major histocompatibility complex class ii alleles hla-drb1*11, hla-dqb1*03 and hla-dqb1*02:02 as risk factors for acquired thrombotic thrombocytopenic purpura development. | |||||||
| 29567779 | HLA-DQB1*03 | thrombotic thrombocytopenic purpura | NA | NA | NA | only_studied | |
| several studies have identified the major histocompatibility complex class ii alleles hla-drb1*11, hla-dqb1*03 and hla-dqb1*02:02 as risk factors for acquired thrombotic thrombocytopenic purpura development. | |||||||
| 29567779 | HLA-DQB1*02 | thrombotic thrombocytopenic purpura | NA | NA | NA | only_studied | |
| several studies have identified the major histocompatibility complex class ii alleles hla-drb1*11, hla-dqb1*03 and hla-dqb1*02:02 as risk factors for acquired thrombotic thrombocytopenic purpura development. | |||||||
| 32253422 | HLA-DR (HLA-DR) | thrombotic thrombocytopenic purpura | Japanese | NA | NA | unclassified | |
| hla loci predisposing to immune ttp in japanese: potential role of the shared adamts13 peptide bound to different hla-dr. immune-mediated thrombotic thrombocytopenic purpura (ittp) is a rare autoimmune disorder caused by neutralizing anti-adamts13 autoantibodies. | |||||||
| 17984617 | HLA (HLA) | malignant hypertension | NA | NA | NA | unclassified | |
| activating antibodies targeting the at1r were detected in the sera from 14 srar victims with malignant hypertension and without anti-hla antibodies. | |||||||
| 6360192 | HLA-DR (HLA-DR) | follicular lymphoma | NA | NA | NA | unclassified | |
| amongst many other features the monoclonality of b cll/lymphomas, the special features of b cll infiltrates (rfa-1+, leu-1+, hla-dr+, smig+), follicular lymphoma deposits (containing follicular dendritic cells) and non-t, non-b acute lymphoblastic leukaemic blasts (terminal transferase+, hla-dr+) as well as the sometimes conspicuous presence of infiltrating normal t cells could be clearly and reproducibly demonstrated. | |||||||
| 7545111 | HLA-CLASS II (HLA CLASS II) | follicular lymphoma | NA | NA | NA | negation | |
| ligation of hla class ii molecules did not alter cd95 expression in the five cell lines examined, except su-dhl-4 originated from a follicular lymphoma, which showed slight up-regulation. | |||||||
| 11019852 | HLA IDENTICAL (HLA-IDENTICAL) | follicular lymphoma | NA | NA | NA | unclassified | |
| a 38-year-old man with refractory follicular lymphoma underwent allogeneic bmt from an hla-identical sibling donor. | |||||||
Copyright 2024